Featured Research

from universities, journals, and other organizations

Leptin's Effect On The Brain's Body Weight Regulation System Is More Complex Than Previously Thought, Yale Researchers Find

Date:
June 7, 2001
Source:
Yale University
Summary:
Leptin, a hormone known for its hunger-blocking effect on the brain, operates in a more complex way than previously thought, researchers from Yale and The Vollum Institute find, possibly leading to development of drugs that can better interfere with appetite and eating behavior to fight obesity and diabetes.

New Haven, Conn. -- Leptin, a hormone known for its hunger-blocking effect on the brain, operates in a more complex way than previously thought, researchers from Yale and The Vollum Institute find, possibly leading to development of drugs that can better interfere with appetite and eating behavior to fight obesity and diabetes.

The researchers say the new finding furthers understanding of how the area of the brain known as the hypothalamus regulates food intake and body weight.

"For the first time, we've shown that leptin does not work like a traditional hormone and affects the brain in more complex ways than a simple hormone does," said Tamas Horvath, associate professor of obstetrics and gynecology and neurobiology at Yale School of Medicine and an author on the study. "Our results show that leptin affects many different levels of neurotransmission."

Published in the May 24 issue of Nature, the study's authors wanted to understand what mechanism leptin uses to regulate brain circuitry, which in turn regulates food intake and energy expenditure. They used genetically altered mice to select, record and label the particular neurotransmitter systems in the hypothalamus that are responsible for food intake and body weight regulation. This allowed for targeted assessment of synaptic transition in the melanocortin system, which is in the core of food intake and energy expenditure regulation.

Horvath said melanocortin-producing neurons were selectively visualized in the laboratories of Malcolm Low and Roger Cone by targeted expression of green fluorescence protein, allowing selective patch-clamp recording from these neurons and parallel assessment of their synaptology. "The fact that the multiple pre- and post-synaptic sites were found to be targeted by leptin offers the possibility of developing drugs with various single and multiple targets, thus development of resistance during chronic administration of one compound could be eliminated by replacement of another," said Horvath.

Past studies on leptin have found that in addition to being critical in body weight regulation and obesity, it also may play a role in diabetic eye disease. Leptin exists in the fatty tissues in areas of the body such as the placenta, ovaries, mammary glands, gastric mucosa and in the liver. The hormone regulates body weight, promotes satiety, decreases appetite, decreases the degree to which the body synthesizes fat and increases the body's ability to burn fat. Overweight or obese people may have a surplus of leptin that is not functional in regulating body weight.

Horvath and his team are currently working with a recently discovered hormone called ghrelin, which has the opposite effect of leptin. "We're trying to see how these two opposing hormones interact in the same circuitry and how either of them are impaired in obesity to enhance understanding of weight disorders," Horvath said.

Co-authors on the study included Michael Cowley, Malcolm J. Low, John L. Smart and Roger Cone of the Vollum Institute, Oregon Health Science University; Marcello Rubinstein and Marcelo G. Cerdan from the University of Buenos Aires; and Sabrina Diano of The Reproductive Neuroscience Unit of the Department of Obstetric and Gynecology at Yale School of Medicine.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Leptin's Effect On The Brain's Body Weight Regulation System Is More Complex Than Previously Thought, Yale Researchers Find." ScienceDaily. ScienceDaily, 7 June 2001. <www.sciencedaily.com/releases/2001/06/010605072819.htm>.
Yale University. (2001, June 7). Leptin's Effect On The Brain's Body Weight Regulation System Is More Complex Than Previously Thought, Yale Researchers Find. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/06/010605072819.htm
Yale University. "Leptin's Effect On The Brain's Body Weight Regulation System Is More Complex Than Previously Thought, Yale Researchers Find." ScienceDaily. www.sciencedaily.com/releases/2001/06/010605072819.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins